Citigroup’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $373K | Sell |
109,643
-46,501
| -30% | -$158K | ﹤0.01% | 3077 |
|
|
2025
Q1 | $626K | Sell |
156,144
-4,051
| -3% | -$16.2K | ﹤0.01% | 2828 |
|
|
2024
Q4 | $1.04M | Buy |
160,195
+18,576
| +13% | +$121K | ﹤0.01% | 2577 |
|
|
2024
Q3 | $785K | Buy |
141,619
+64,563
| +84% | +$358K | ﹤0.01% | 2728 |
|
|
2024
Q2 | $430K | Buy |
77,056
+12,927
| +20% | +$72.1K | ﹤0.01% | 2788 |
|
|
2024
Q1 | $430K | Buy |
64,129
+3,075
| +5% | +$20.6K | ﹤0.01% | 2946 |
|
|
2023
Q4 | $557K | Buy |
61,054
+22,883
| +60% | +$209K | ﹤0.01% | 2616 |
|
|
2023
Q3 | $211K | Sell |
38,171
-31,805
| -45% | -$176K | ﹤0.01% | 2961 |
|
|
2023
Q2 | $598K | Buy |
69,976
+60,074
| +607% | +$513K | ﹤0.01% | 2615 |
|
|
2023
Q1 | $91K | Buy |
9,902
+7,384
| +293% | +$67.9K | ﹤0.01% | 3425 |
|
|
2022
Q4 | $25.7K | Sell |
2,518
-978
| -28% | -$9.99K | ﹤0.01% | 3810 |
|
|
2022
Q3 | $52K | Sell |
3,496
-5,603
| -62% | -$83.3K | ﹤0.01% | 3653 |
|
|
2022
Q2 | $97K | Buy |
9,099
+4,653
| +105% | +$49.6K | ﹤0.01% | 3566 |
|
|
2022
Q1 | $48K | Buy |
4,446
+275
| +7% | +$2.97K | ﹤0.01% | 4040 |
|
|
2021
Q4 | $68K | Buy |
4,171
+1,944
| +87% | +$31.7K | ﹤0.01% | 4165 |
|
|
2021
Q3 | $48K | Buy |
+2,227
| New | +$48K | ﹤0.01% | 4008 |
|